Members of the Artiva management team will also be av SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission ...
Artiva Biotherapeutics’ (NASDAQ:ARTV – Get Free Report) lock-up period is set to expire on Wednesday, January 15th. Artiva Biotherapeutics had issued 13,920,000 shares in its IPO on July 19th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback